IP Verse

Gillard patent opposition analysis

The comprehensive analysis of Gillard opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Gillard

Stay updated with the latest patent oppositions filed by Gillard

Patent NumberTitleApplicantOpposition DateOpposition Company
EP1925308
Low Hygroscopic Aripiprazole (Crystal G) Drug Substance And Processes For The Preparation ThereofOTSUKA PHARMACEUTICALApr 10, 2017PHARMACEUTICAL WORKS POLPHARMA
EP2036557
Antitumor Agent For Thyroid CancerEISAI R&D MANAGEMENTJul 18, 2016ACTAVIS GROUP PTC EHF
EP2311434
Dry Powder Inhaler Formulations Comprising Surface-Modified Particles With Anti-Adherent AdditivesVECTURAApr 8, 2016TEVA UK LIMITED
EP1492505
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEDec 11, 2015ACTAVIS GROUP PTC EHF
EP2011485
Once-A-Day Oxycodone FormulationsEURO CELTIQUESep 3, 2015ACTAVIS GROUP PTC EHF
EP2105135
Pharmaceutical Compositions For Treating CancerCELGENEJul 21, 2015GENERICS UK TRADING MYLAN
EP2328820
A Uv-Protected Container With Product Having Dyes Or LakesCOLGATE PALMOLIVEMay 20, 2015THE PROCTER & GAMBLE

Top clients of Gillard

Top companies who are the clients of Gillard

CompanyTotal
ACTAVIS GROUP PTC EHF3
GENERICS UK TRADING MYLAN1
PHARMACEUTICAL WORKS POLPHARMA1
TEVA UK LIMITED1
THE PROCTER & GAMBLE1